The frequency and density of CADM1 promoter methylation increases with high-grade precancerous lesions and cancer compared to normal tissue, and it ranges from 5% in normal tissue to more than 80% in cervical cancer lesions [88,89]. The gene discussed is CADM1; the disease is cervical cancer.